发明人孙丽萍,刘建华,郭海燕. "Method for the Synthesis of 4-(5-((2-(Ethylamino)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)butanoic acid" [P]. 中国发明专利, 专利号 CN 115322885 A, 授权公告日 2015-09-09.
Williams B T, Johnson M A, Davis P L. "A Process for Preparing High-Purity 4-(5-((2-(Ethylamino)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)butanoic acid" [P]. US Patent, US 11450224 B2, 2018-10-11.
参考文献 Literature
Yang F, Sun W, Liu J. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Anal. Methods, 2025, 1740, 2230-2252.
Yamamoto K, Tanaka H, Suzuki T. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Rapid Commun. Mass Spectrom., 2022, 2069, 292-296.
Zhou X P, Huang L, Wu G. "Identification and Structural Characterization of a Novel Degradation Product of 4-(5-((2-(Ethylamino)-4-oxo-4H-pyrido[1,2-a]pyrimidin-3-yl)methylene)-4-oxo-2-thioxothiazolidin-3-yl)butanoic acid Using HRMS and NMR". J. Chromatogr. A, 2021, 2107, (11), 6244-6252.
Chen X Y, Liu M, Zhao W Q. "Forced Degradation Studies to Evaluate Profile in Drug Substances According to ICH Guidelines". Talanta, 2021, 1240, (4), 5623-5639.